Long-Term Survival and Biomarker Analysis Evaluating Neoadjuvant Plus Adjuvant Relatlimab (anti-LAG3) and Nivolumab (anti-PD1) in Patients With Resectable Melanoma Our study included a broad cohort of ...
Application of Generative Artificial Intelligence for Physician and Patient Oncology Letters—AI-OncLetters The development cohort comprises 254 patients from three clinical trials. Nine clinical ...
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する